Perfromance Wealth Partners, LLC Merck & Co., Inc. Transaction History

Perfromance Wealth Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$123.8 - $132.96 $225,563 - $242,253	1,822 Added 3.81%	49,646 $6.15 Million
Q1 2024 Apr 30, 2024	BUY	$113.24 - $131.95 $273,361 - $318,527	2,414 Added 5.32%	47,824 $6.31 Million
Q4 2023 Jan 22, 2024	SELL	$100.18 - $109.02 $228,510 - $248,674	-2,281 Reduced 4.78%	45,410 $4.95 Million
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $517,838 - $575,079	5,030 Added 11.79%	47,691 $4.91 Million
Q2 2023 Jul 13, 2023	BUY	$108.61 - $118.38 $614,732 - $670,030	5,660 Added 15.3%	42,661 $4.92 Million
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $1.04 Million - $1.16 Million	10,134 Added 37.72%	37,001 $3.94 Million
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $889,876 - $1.14 Million	10,177 Added 60.98%	26,867 $0
Q3 2022 Oct 17, 2022	BUY	$84.53 - $94.96 $236,684 - $265,888	2,800 Added 20.16%	16,690 $1.44 Million
Q2 2022 Jul 15, 2022	BUY	$83.49 - $94.64 $146,024 - $165,525	1,749 Added 14.41%	13,890 $1.27 Million
Q4 2021 Feb 03, 2022	BUY	$72.28 - $90.54 $877,551 - $1.1 Million	12,141 New	12,141 $930,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.